<DOC>
	<DOCNO>NCT00765895</DOCNO>
	<brief_summary>The principal objective multicenter , randomize , placebo-controlled trial evaluate whether treatment nortriptyline improve gastroparesis symptom compare placebo .</brief_summary>
	<brief_title>Nortriptyline Idiopathic Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>Age 21 65 year old registration Documentation delay gastric empty gastric empty scintigraphy within 2 year registration , define great 60 % retention 2 hour great 10 % retention 4 hour Symptoms gastroparesis least 6 month ( contiguous ) prior registration Gastroparesis Cardinal Symptom Index ( GCSI ) score 21 great Negative upper endoscopy upper GI series within 2 year registration Normal gastric emptying confirm scintigraphy Diabetic gastroparesis postsurgical gastroparesis include fundoplication Another active disorder could explain symptoms opinion investigator History significant cardiac arrhythmia and/or prolong QTc History seizure Use narcotic 3 day per week Use tricyclic antidepressant refractory symptom gastroparesis within 6 week prior randomization Use strongly anticholinergic medication Use calcium channel blocker Use erythromycin Clear history fail trial nortriptyline use gastroparetic symptom Symptoms primary depression suicidal ideation Contraindications nortriptyline : 1. hypersensitivity allergy tricyclic antidepressant drug 2. concomitant therapy monoamine oxidase inhibitor ( MAOI ) 3. recent myocardial infarction 4. glaucoma Pregnancy nursing Any condition , opinion investigator would impede compliance hinder completion study Use G tube , J tube , central catheter nutrition Use gastric electrical stimulator Failure give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>idiopathic gastroparesis</keyword>
</DOC>